were the first to identify that exosomes derived from hypoxic brain cancer exhibited notably elevated levels of monocarboxylate transporter 1 (MCT1) and CD147 (a transmembrane glycoprotein associated with tumors). Here, SLC16A1 is linked to brain cancer.